Aperio Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$6.54M Buy
89,365
+5,888
+7% +$431K 0.02% 717
2020
Q3
$6.49M Buy
83,477
+19,086
+30% +$1.48M 0.02% 649
2020
Q2
$3.58M Sell
64,391
-6,136
-9% -$341K 0.01% 861
2020
Q1
$2.09M Buy
70,527
+27,552
+64% +$816K 0.01% 998
2019
Q4
$1.56M Buy
42,975
+40
+0.1% +$1.45K 0.01% 1206
2019
Q3
$1.17M Buy
42,935
+6,868
+19% +$187K ﹤0.01% 1316
2019
Q2
$868K Buy
36,067
+676
+2% +$16.3K ﹤0.01% 1473
2019
Q1
$935K Buy
35,391
+9,743
+38% +$257K ﹤0.01% 1398
2018
Q4
$501K Buy
25,648
+7,360
+40% +$144K ﹤0.01% 1677
2018
Q3
$358K Buy
18,288
+1,873
+11% +$36.7K ﹤0.01% 1934
2018
Q2
$272K Buy
+16,415
New +$272K ﹤0.01% 2038